Cargando…

Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey

BACKGROUND: First reported in 1955, Cronkhite–Canada syndrome (CCS), a rare syndrome characterized by ectodermal abnormalities and inflammatory changes of the gastrointestinal tract mucosa, has been associated with a poor prognosis and life-threatening malignant complications. In a large population...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Chikako, Komoto, Shunsuke, Tomita, Kengo, Hokari, Ryota, Tanaka, Masanori, Hirata, Ichiro, Hibi, Toshifumi, Kaunitz, Jonathan D., Miura, Soichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805704/
https://www.ncbi.nlm.nih.gov/pubmed/26216651
http://dx.doi.org/10.1007/s00535-015-1107-7
_version_ 1782423188683096064
author Watanabe, Chikako
Komoto, Shunsuke
Tomita, Kengo
Hokari, Ryota
Tanaka, Masanori
Hirata, Ichiro
Hibi, Toshifumi
Kaunitz, Jonathan D.
Miura, Soichiro
author_facet Watanabe, Chikako
Komoto, Shunsuke
Tomita, Kengo
Hokari, Ryota
Tanaka, Masanori
Hirata, Ichiro
Hibi, Toshifumi
Kaunitz, Jonathan D.
Miura, Soichiro
author_sort Watanabe, Chikako
collection PubMed
description BACKGROUND: First reported in 1955, Cronkhite–Canada syndrome (CCS), a rare syndrome characterized by ectodermal abnormalities and inflammatory changes of the gastrointestinal tract mucosa, has been associated with a poor prognosis and life-threatening malignant complications. In a large population survey, we endeavored to characterize the course and treatment outcome of CCS through clinical and endoscopic assessment, and to explore its optimal treatment and surveillance strategy. METHODS: A retrospective analysis of 210 patients with CCS was conducted via a questionnaire-based nationwide survey of 983 teaching hospitals located throughout Japan. We assessed clinical features, endoscopic findings, treatments used, and short- and long-term outcomes. RESULTS: The average age at diagnosis was 63.5 years. In all cases, upper or lower gastrointestinal tract polyposis was confirmed, accompanied by characteristic ectodermal abnormalities. Of the treatments used, oral corticosteroids (30–49 mg/day) were the most effective treatment for active disease, with adjunctive nutritional support considered beneficial. With corticosteroid treatment, abdominal symptoms were relieved within a few months, whereas polyp regression often required more than 6 months. Maintenance of endoscopic remission with or without steroids for 3 years significantly lowered the development of CCS-related cancer, compared with relapsers or nonresponders, underscoring the importance of sustained endoscopic remission for cancer prevention. CONCLUSIONS: The prognosis of CCS has greatly improved through the use of improved medical treatment. Although CCS continues to be relentlessly progressive, carrying a high cancer risk, a sufficient dose and duration of corticosteroid therapy accompanied by nutritional support and periodic endoscopic surveillance appears to improve its natural history. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-015-1107-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4805704
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-48057042016-04-09 Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey Watanabe, Chikako Komoto, Shunsuke Tomita, Kengo Hokari, Ryota Tanaka, Masanori Hirata, Ichiro Hibi, Toshifumi Kaunitz, Jonathan D. Miura, Soichiro J Gastroenterol Original Article—Alimentary Tract BACKGROUND: First reported in 1955, Cronkhite–Canada syndrome (CCS), a rare syndrome characterized by ectodermal abnormalities and inflammatory changes of the gastrointestinal tract mucosa, has been associated with a poor prognosis and life-threatening malignant complications. In a large population survey, we endeavored to characterize the course and treatment outcome of CCS through clinical and endoscopic assessment, and to explore its optimal treatment and surveillance strategy. METHODS: A retrospective analysis of 210 patients with CCS was conducted via a questionnaire-based nationwide survey of 983 teaching hospitals located throughout Japan. We assessed clinical features, endoscopic findings, treatments used, and short- and long-term outcomes. RESULTS: The average age at diagnosis was 63.5 years. In all cases, upper or lower gastrointestinal tract polyposis was confirmed, accompanied by characteristic ectodermal abnormalities. Of the treatments used, oral corticosteroids (30–49 mg/day) were the most effective treatment for active disease, with adjunctive nutritional support considered beneficial. With corticosteroid treatment, abdominal symptoms were relieved within a few months, whereas polyp regression often required more than 6 months. Maintenance of endoscopic remission with or without steroids for 3 years significantly lowered the development of CCS-related cancer, compared with relapsers or nonresponders, underscoring the importance of sustained endoscopic remission for cancer prevention. CONCLUSIONS: The prognosis of CCS has greatly improved through the use of improved medical treatment. Although CCS continues to be relentlessly progressive, carrying a high cancer risk, a sufficient dose and duration of corticosteroid therapy accompanied by nutritional support and periodic endoscopic surveillance appears to improve its natural history. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00535-015-1107-7) contains supplementary material, which is available to authorized users. Springer Japan 2015-07-28 2016 /pmc/articles/PMC4805704/ /pubmed/26216651 http://dx.doi.org/10.1007/s00535-015-1107-7 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article—Alimentary Tract
Watanabe, Chikako
Komoto, Shunsuke
Tomita, Kengo
Hokari, Ryota
Tanaka, Masanori
Hirata, Ichiro
Hibi, Toshifumi
Kaunitz, Jonathan D.
Miura, Soichiro
Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
title Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
title_full Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
title_fullStr Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
title_full_unstemmed Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
title_short Endoscopic and clinical evaluation of treatment and prognosis of Cronkhite–Canada syndrome: a Japanese nationwide survey
title_sort endoscopic and clinical evaluation of treatment and prognosis of cronkhite–canada syndrome: a japanese nationwide survey
topic Original Article—Alimentary Tract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805704/
https://www.ncbi.nlm.nih.gov/pubmed/26216651
http://dx.doi.org/10.1007/s00535-015-1107-7
work_keys_str_mv AT watanabechikako endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT komotoshunsuke endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT tomitakengo endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT hokariryota endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT tanakamasanori endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT hirataichiro endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT hibitoshifumi endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT kaunitzjonathand endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey
AT miurasoichiro endoscopicandclinicalevaluationoftreatmentandprognosisofcronkhitecanadasyndromeajapanesenationwidesurvey